Cleared Special

VISENSIA, VISENSIA WITH ALERT (K110953) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K110953 · Obs Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
71d
Days
Class 2
Risk

K110953 is an FDA 510(k) clearance for the VISENSIA, VISENSIA WITH ALERT. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Obs Medical (In The Vale Oxford, GB). The FDA issued a Cleared decision on June 15, 2011 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Obs Medical devices

Submission Details

510(k) Number K110953 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2011
Decision Date June 15, 2011
Days to Decision 71 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 424
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K110953.
Radius VSM and Accessories
K254209 · Masimo Corporation · Jun 2026
M12 Telemetry System
K252840 · Global Instrumentation, LLC · May 2026
ePM Series Patient Monitor (ePM 10/ePM 10A/ePM 10C/Guardian plus/ ePM 12/ePM 12A/ePM 12C / ePM 15/ePM 15A/ePM 15C /ePM 10M/ ePM 10MA/ ePM 10MC/ePM 12M/ ePM 12MA/ ePM 12MC/ePM 15M/ ePM 15MA/ ePM 15MC)
K260098 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · May 2026
Vista CMS
K250349 · Shanghai Draeger Medical Instrument Co., Ltd. · Apr 2026
uMEC 60/ uMEC 70/ uMEC 80/uMEC 100/uMEC 120/uMEC 150 Patient Monitors
K253170 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2026
Vista 300/Vista 300 S
K252250 · Shanghai Draeger Medical Instrument Co., Ltd. · Apr 2026